StreetInsider.com News Articles

Form 4 EXOZYMES INC. For: Oct 09 Filed by: Perriman Damien Alan

Mon, 26 Oct 2026 15:01:00 -0400

si-local-file:///var/storage/secattach/20261026/27233556.html

Form 4/A EXOZYMES INC. For: Aug 19 Filed by: Korman Tyler Paz

Wed, 21 Oct 2026 06:05:00 -0400

si-local-file:///var/storage/secattach/20261021/27212545.html

Form 4 EXOZYMES INC. For: Oct 01 Filed by: Rayo Edgardo Javier

Mon, 19 Oct 2026 19:48:00 -0400

si-local-file:///var/storage/secattach/20261019/27205069.html

Form 4 EXOZYMES INC. For: Oct 01 Filed by: MARLETT CHRISTOPHER A

Mon, 19 Oct 2026 19:48:00 -0400

si-local-file:///var/storage/secattach/20261019/27205068.html

Form 4 EXOZYMES INC. For: Oct 01 Filed by: Bowie James Ulrich

Mon, 19 Oct 2026 19:47:00 -0400

si-local-file:///var/storage/secattach/20261019/27205064.html

Form 4 EXOZYMES INC. For: Oct 01 Filed by: DIGIANDOMENICO ANTHONY

Mon, 19 Oct 2026 19:47:00 -0400

si-local-file:///var/storage/secattach/20261019/27205065.html

Form 4 EXOZYMES INC. For: Oct 01 Filed by: Lalonde James Joseph

Mon, 19 Oct 2026 19:47:00 -0400

si-local-file:///var/storage/secattach/20261019/27205066.html

Form 4 EXOZYMES INC. For: Oct 01 Filed by: BELL LON E

Mon, 19 Oct 2026 19:46:00 -0400

si-local-file:///var/storage/secattach/20261019/27205061.html

Form 8-K EXOZYMES INC. For: Oct 09

Fri, 09 Oct 2026 12:11:00 -0400

si-local-file:///var/storage/secattach/20261009/27170530.html

Form DEFA14A EXOZYMES INC.

Mon, 28 Sep 2026 17:26:00 -0400

si-local-file:///var/storage/secattach/20260928/27115608.html

Form DEF 14A EXOZYMES INC. For: Nov 13

Mon, 28 Sep 2026 17:25:00 -0400

si-local-file:///var/storage/secattach/20260928/27115596.html

Form 8-K EXOZYMES INC. For: Sep 17

Fri, 18 Sep 2026 13:25:00 -0400

si-local-file:///var/storage/secattach/20260918/27079938.html

Form 4 EXOZYMES INC. For: Sep 14 Filed by: Nawaz Fouad

Thu, 17 Sep 2026 17:27:00 -0400

si-local-file:///var/storage/secattach/20260917/27076886.html

eXoZymes picks Curia Global to scale NCT manufacturing process

Tue, 08 Sep 2026 10:23:12 -0400

eXoZymes Inc. (NASDAQ: EXOZ) has entered into an agreement with Curia Global, Inc. to transfer and scale its NCT manufacturing process toward commercial production, according to a press release from the company.

Under the agreement, eXoZymes will transfer its NCT manufacturing process to Curia, which will scale the process at its facilities in León, Spain, and Rozzano, Italy. The work includes cross-validation of eXoZymes' enzyme fermentation, cell-free reaction, and purification processes. The program also includes process modeling and engineering analysis to define a path to larger-scale manufacturing.

The program is expected to begin in the fourth quarter of 2026 and is designed

eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT

Tue, 08 Sep 2026 10:20:00 -0400

Program expected to commence in Q4 2026 and establish a roadmap for larger-scale production in 2027

LOS ANGELES, CA / ACCESS Newswire / September 8, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that transform abundant feedstock into valuable nutraceuticals and novel medicines - announced that it has entered into an agreement with Curia Global, Inc. ("Curia"), a global leader in contract manufacturing, to initiate technology

The agreement represents the next major step in advancing eXoZymes' proprietary NCT manufacturing process from successful pilot-scale validation toward commercial manufacturing.

Damien

eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT

Tue, 08 Sep 2026 10:20:00 -0400

Program expected to commence in Q4 2026 and establish a roadmap for larger-scale production in 2027

The agreement represents the next major step in advancing eXoZymes' proprietary NCT manufacturing process from successful pilot-scale validation toward commercial manufacturing.

Damien

Form 4 EXOZYMES INC. For: Aug 19 Filed by: Perriman Damien Alan

Tue, 25 Aug 2026 19:17:00 -0400

si-local-file:///var/storage/secattach/20260825/26976034.html

Form 4 EXOZYMES INC. For: Aug 19 Filed by: Perriman Damien Alan

Tue, 25 Aug 2026 19:17:00 -0400

si-local-file:///var/storage/secattach/20260825/26976034.html

Form 4 EXOZYMES INC. For: Aug 19 Filed by: Korman Tyler Paz

Tue, 25 Aug 2026 18:58:00 -0400

si-local-file:///var/storage/secattach/20260825/26975948.html

Form 4 EXOZYMES INC. For: Aug 19 Filed by: Korman Tyler Paz

Tue, 25 Aug 2026 18:58:00 -0400

si-local-file:///var/storage/secattach/20260825/26975948.html

eXoZymes Reports Second Quarter 2026 Results and Provides Business Update at 5PM ET Today

Thu, 20 Aug 2026 16:10:00 -0400

Management to host Q2 2026 update at 5PM ET / 2PM PT, today.

LOS ANGELES, CA / ACCESS Newswire / August 20, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that transform abundant feedstock into valuable nutraceuticals and novel medicines - will host an investor webinar today at 5:00 PM Eastern Time to discuss results for the second quarter ended June 30, 2026, and provide an update on recent business developments.

Michael Heltzen, CEO of eXoZymes, states, "We have taken a molecule from

eXoZymes Reports Second Quarter 2026 Results and Provides Business Update at 5PM ET Today

Thu, 20 Aug 2026 16:10:00 -0400

Management to host Q2 2026 update at 5PM ET / 2PM PT, today.

LOS ANGELES, CA / ACCESS Newswire / August 20, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that transform abundant feedstock into valuable nutraceuticals and novel medicines - will host an investor webinar today at 5:00 PM Eastern Time to discuss results for the second quarter ended June 30, 2026, and provide an update on recent business developments.
Michael Heltzen, CEO of eXoZymes, states, "We have taken a molecule from

eXoZymes reports 10-fold productivity gain in NCT manufacturing

Tue, 18 Aug 2026 16:31:30 -0400

eXoZymes Inc. (NASDAQ: EXOZ) announced improvements to its manufacturing process for N-trans-caffeoyltyramine (NCT), a compound the company is developing for nutraceutical and pharmaceutical applications.
According to a press release from the Los Angeles-based company, the optimized process produced approximately 67% more NCT per liter compared to a previously announced 100-liter pilot run, while reducing reaction time by more than 80%. The company said these combined changes resulted in a tenfold increase in manufacturing productivity.
eXoZymes said internal process-cost assessments indicate the estimated manufacturing cost equivalent has declined more than 100 times from the first version of the NCT process to the current

eXoZymes' NCT Process Achieves 10-fold Productivity Increase, Advancing Beyond Original Commercial-scale Economic Targets

Tue, 18 Aug 2026 16:30:00 -0400

Optimized process delivered a 10-fold improvement in productivity, significantly improving the estimated economics of future commercial-scale manufacturing.
Estimated manufacturing cost equivalent has fallen more than 100x from the first version of the NCT process to the current optimized process, based on internal process-cost assessments.
The new process produced approximately 67% more NCT per liter than the previously announced 100-liter pilot run.
Reaction time was reduced by over 80%, allowing substantially more product to be produced in less time.
The improvements support a more scalable and efficient manufacturing process as eXoZymes prepares for technology transfer to future commercial partners.

eXoZymes' NCT Process Achieves 10-fold Productivity Increase, Advancing Beyond Original Commercial-scale Economic Targets

Tue, 18 Aug 2026 16:30:00 -0400

Optimized process delivered a 10-fold improvement in productivity, significantly improving the estimated economics of future commercial-scale manufacturing.
Estimated manufacturing cost equivalent has fallen more than 100x from the first version of the NCT process to the current optimized process, based on internal process-cost assessments.
The new process produced approximately 67% more NCT per liter than the previously announced 100-liter pilot run.
Reaction time was reduced by over 80%, allowing substantially more product to be produced in less time.
The improvements support a more scalable and efficient manufacturing process as eXoZymes prepares for technology transfer to future commercial partners.